These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9146608

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
    Robert M, Gibbs BF, Jacobson E, Gagnon C.
    Biochemistry; 1997 Apr 01; 36(13):3811-9. PubMed ID: 9092810
    [Abstract] [Full Text] [Related]

  • 5. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED, Smith ND, Grayhack JT.
    J Urol; 1995 Nov 01; 154(5):1802-5. PubMed ID: 7563351
    [Abstract] [Full Text] [Related]

  • 6. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.
    Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461
    [Abstract] [Full Text] [Related]

  • 7. Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis.
    Charrier JP, Tournel C, Michel S, Comby S, Jolivet-Reynaud C, Passagot J, Dalbon P, Chautard D, Jolivet M.
    Electrophoresis; 2001 May 15; 22(9):1861-6. PubMed ID: 11425243
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.
    Mikolajczyk SD, Millar LS, Wang TJ, Rittenhouse HG, Marks LS, Song W, Wheeler TM, Slawin KM.
    Cancer Res; 2000 Feb 01; 60(3):756-9. PubMed ID: 10676664
    [Abstract] [Full Text] [Related]

  • 10. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia.
    Nakamura T, Scorilas A, Stephan C, Jung K, Soosaipillai AR, Diamandis EP.
    Cancer Res; 2003 Oct 01; 63(19):6543-6. PubMed ID: 14559849
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.
    Zhang WM, Finne P, Leinonen J, Stenman UH.
    Scand J Clin Lab Invest Suppl; 2000 Oct 01; 233():51-8. PubMed ID: 11317942
    [Abstract] [Full Text] [Related]

  • 13. Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia.
    Charrier JP, Tournel C, Michel S, Dalbon P, Jolivet M.
    Electrophoresis; 1999 Oct 01; 20(4-5):1075-81. PubMed ID: 10344287
    [Abstract] [Full Text] [Related]

  • 14. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ.
    J Urol; 1999 Nov 01; 162(5):1587-90. PubMed ID: 10524873
    [Abstract] [Full Text] [Related]

  • 15. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Elgeti U, Brux B, Sinha P, Schnorr D, Loening SA.
    Anticancer Res; 2000 Nov 01; 20(6D):4997-5001. PubMed ID: 11326657
    [Abstract] [Full Text] [Related]

  • 16. alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.
    Fukushima K, Satoh T, Baba S, Yamashita K.
    Glycobiology; 2010 Jan 01; 20(4):452-60. PubMed ID: 20008118
    [Abstract] [Full Text] [Related]

  • 17. Prostate-specific antigen.
    Stenman UH, Leinonen J, Zhang WM, Finne P.
    Semin Cancer Biol; 1999 Apr 01; 9(2):83-93. PubMed ID: 10202130
    [Abstract] [Full Text] [Related]

  • 18. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
    Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, Habuchi T, Arai Y, Fukuda M.
    Glycobiology; 2004 Aug 01; 14(8):671-9. PubMed ID: 15044396
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar 01; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.